Maurizia Lanza

Dr. Maurizia Lanza


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AAanna annunziata
anna annunziata
IFilaria ferrarotti
ilaria ferrarotti
Antonietta CoppolaAntonietta Coppola
Antonietta Coppola
MLMaurizia Lanza
Maurizia Lanza
PIPasquale Imitazione
Pasquale Imitazione
GFGiuseppe Fiorentino
Giuseppe Fiorentino
Introduction. Alpha-1 antitrypsin deficiency (AATD) is a genetic condition associated with several respiratory diseases in patients with severe protein deficiency. AATD is often late diagnosed or underdiagnosed. Diagnosis frequently occurs in patients with chronic obstructive pulmonary disease and emphysema characterized by frequent exacerbations and over ten years’ duration. The purpose of this study was to evaluate the incidence of alpha-1 antitrypsin deficiency in patients with the chronic pulmonary disease after a thorough screening in the city of Naples in southern Italy. Materials and methods. Two hundred patients suffering from respiratory pathology (chronic obstructive pulmonary disease (COPD), emphysema, asthma, or bronchiectasis) were examined and evaluated in our outpatients’ clinic and tested for serum levels of AAT. Patients who had a respiratory disease suspected of AATD and/or serum AAT < 120 mg/dL underwent genetic testing. Genetic screening was performed on samples from 141 patients. Results. A total of 36 patients had an intermediate deficiency of AAT levels. Among them, 8 were PI*MZ, 6 were PI*MS and 22 had rare pathological mutations. Five patients had a severe AATD, all were composite heterozygous with S or Z allele, while the other allele had a rare pathological mutation. Conclusions. The incidence of genetic defects as AATD in the population of patients affected by chronic respiratory disorders is always a matter of discussion because of the frequent interaction between genes and environmental causes. In our series, numerous rare variants and compound heterozygosity have been described. No homozygous patients have been described. The present is one of few studies available on the incidence of rare variants in the geographic area of the city of Naples. So, our results could be considered interesting not only to know the incidence of AATD and its related rare mutations but also to support early diagnosis and treatments for patients with chronic pulmonary disease and frequent exacerbation and to fight the association with environmental causes of pulmonary damages as smoking.

18 October 2021 in Medicina
Verified
Journal Article
Open access
PDF file
GPGiorgio Emanuele Polistina
Giorgio Emanuele Polistina
MLMaurizia Lanza
Maurizia Lanza
CSCamilla Di Somma
Camilla Di Somma
AAanna annunziata
anna annunziata
GFGiuseppe Fiorentino
Giuseppe Fiorentino
Infection with severe acute respiratory syndrome coronavirus 2 causes coronavirus disease 2019 (COVID-19) which was revealed an official pandemic by the World Health Organization on 11 March 2020. The current pandemic, the third of this decade, is the worst in terms of suffering and deaths related. COVID-19 represents an unprecedented challenge for medical communities and patients around the world. High-resolution computed tomography of the chest (HRCT) is a fundamental tool in both management and diagnosis of the disease. Imaging plays an essential role in the diagnosis of all the manifestations of the disease and its complications and the correct use and interpretation of imaging tests are essential. Pneumomediastinum has been reported rarely in COVID-19 patients. We were one of the first groups to share our experiences in uncommon parenchymal complications of COVID-19 with spontaneous pneumothorax and pneumomediastinum, but also with new-onset bronchiectasis and cysts. A finding of pneumopericardium is also unusual. We hereby report a rare case of spontaneous pneumopericardium in a patient with COVID-19 pneumonia treated only with a high-flow nasal cannula (HFNC).

28 September 2019
Verified
Conference Paper
Closed access
MLMaurizia Lanza
Maurizia Lanza
IMIlernando Meoli
Ilernando Meoli
RCRosa Cauteruccio
Rosa Cauteruccio
FSFrancesco Stefanelli
Francesco Stefanelli
AGAngela Di Giorgio
Angela Di Giorgio
GFGiuseppe Fiorentino
Giuseppe Fiorentino
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic, devastating, interstitial lung disease, with few therapeutic options. IPF is characterized by pulmonary restriction, dyspnea, hypoxemia, exercise intolerance and poor quality of life (QOL). Aims and objective: We aimed to examine the effect of exercise training (ET) on clinical outcomes and on quality of life and symptoms in IPF patients. Methods: Subjects who met current criteria for IPF were randomized to a 3-month pulmonary rehabilitation program (n _ 14) or to a control group (n _ 10). The rehabilitation group participated in twiceweekly, 90-min exercise sessions (24 total sessions). The control group maintained its preceding normal physical activity. 6-min walking distance (6MWD) test, 30-second chair-stand test, pulmonary function tests, dyspnea and QOL were assessed at baseline and at the end of the 12-week intervention. The SGRQ-I and a 5-point self-assessment of health were completed at baseline, after 3 months of intervention or observation. Results: Subjects in the rehabilitation group maintained significantly higher levels of physical activity throughout the 3-month rehabilitation program. SGRQ-I symptom domain scores improved considerably by _9 _ 22 in the rehabilitation group, whereas in the control group they worsened Significant differences were observed between the ET and the control groups in raw mean: Δ6MWD, 94 m, p < 0.001; Dyspnea, QOL and 30-second chairstand were also improved significantly. Conclusion: ET improves exercise tolerance, functional capacity, pulmonary function, dyspnea and QOL in patients with IPF and should be considered the standard care for IPF.

21 March 2020 in Anaesthesiology Intensive Therapy
Verified
Journal Article
Open access
GFGiuseppe Fiorentino
Giuseppe Fiorentino
MLMaurizia Lanza
Maurizia Lanza
SSSara Spinelli
Sara Spinelli
PIPasquale Imitazione
Pasquale Imitazione
AAAnna Annunziata
Anna Annunziata

9 June 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
AAanna annunziata
anna annunziata
LALidia Atripaldi
Lidia Atripaldi
RRRoberto Rega
Roberto Rega
AGAnna Michela Gaeta
Anna Michela Gaeta
MMMariano Mollica
Mariano Mollica
GFGiuseppe Fiorentino
Giuseppe Fiorentino
Background/Objectives: Birt-Hogg-Dubé (BHD) syndrome is a rare autosomal dominant disorder caused by germline pathogenic variants in the FLCN gene. Although it carries a substantial lifetime risk of renal cell carcinoma, its earliest manifestations are typically pulmonary cysts and spontaneous pneumothorax, which are frequently misclassified as primary spontaneous pneumothorax, resulting in diagnostic delay and inadequate oncological surveillance. We aimed to characterise the real-world phenotypic spectrum of BHD encountered in a respiratory referral setting. Methods: We retrospectively describe seven consecutive patients with genetically confirmed BHD syndrome diagnosed at our tertiary referral centre between 2022 and 2024. Demographic data, smoking history, FLCN variants, pneumothorax episodes, HRCT findings, pulmonary function tests and extrapulmonary neoplasms were collected. Reporting followed the PROCESS 2020 guideline. Results: Mean age at genetic diagnosis was 53.1 years (range 41–64). All seven patients had multiple thin-walled pulmonary cysts on HRCT, with the typical basal, subpleural and paramediastinal distribution; three had a pneumothorax history. Despite largely preserved spirometry (mean FEV1 82.4% predicted), DLCO was reduced in five patients (mean 67.4% predicted) and was the most frequently affected functional parameter, although the overall functional picture was heterogeneous. Five patients had solid neoplasms (one renal, one colorectal, one thyroid/parathyroid, one ovarian, one lung adenocarcinoma). Conclusions: In this referral-based case series, pulmonary cysts were a constant finding and DLCO was the most frequently reduced functional parameter, although the functional picture varied across patients. These descriptive observations are hypothesis-generating and require prospective, controlled validation—including comparison with other diffuse cystic lung diseases—before any diagnostic algorithm can be proposed.

Verified
Journal Article
Open access
PDF file
AAanna annunziata
anna annunziata
LALidia Atripaldi
Lidia Atripaldi
RRRoberto Rega
Roberto Rega
AGAnna Michela Gaeta
Anna Michela Gaeta
MMMariano Mollica
Mariano Mollica
GFGiuseppe Fiorentino
Giuseppe Fiorentino
Background/Objectives: Birt–Hogg–Dubé (BHD) syndrome is a rare autosomal dominant disorder caused by germline pathogenic variants in the folliculin (FLCN) gene. Although it carries a substantial lifetime risk of renal cell carcinoma, its earliest manifestations are typically pulmonary cysts and spontaneous pneumothorax, which are frequently misclassified as primary spontaneous pneumothorax, resulting in diagnostic delay and inadequate oncological surveillance. We aimed to characterise the real-world phenotypic spectrum of BHD encountered in a respiratory referral setting. Methods: We retrospectively describe seven consecutive patients with genetically confirmed BHD syndrome diagnosed at our tertiary referral centre between 2022 and 2024. Demographic data, smoking history, FLCN variants, pneumothorax episodes, high-resolution computed tomography (HRCT) findings, pulmonary function tests and extrapulmonary neoplasms were collected. Reporting followed the PROCESS 2020 guideline. Results: Mean age at genetic diagnosis was 53.1 years (range 41–64). All seven patients had multiple thin-walled pulmonary cysts on HRCT, with the typical basal, subpleural and paramediastinal distribution; three had a pneumothorax history. Despite largely preserved spirometry—mean forced expiratory volume in 1 s (FEV1) of 82.4% predicted—the diffusing capacity of the lung for carbon monoxide (DLCO) was reduced in five patients (mean of 67.4% predicted) and was the most frequently affected functional parameter, although the overall functional picture was heterogeneous. Five patients had solid neoplasms (one renal, one colorectal, one thyroid/parathyroid, one ovarian, one lung adenocarcinoma). Conclusions: In this referral-based case series, pulmonary cysts were a constant finding and DLCO was the most frequently reduced functional parameter, although the functional picture varied across patients. These descriptive observations are hypothesis-generating and require prospective, controlled validation—including comparison with other diffuse cystic lung diseases—before any diagnostic algorithm can be proposed.